NL-OMON41715已完成不适用
*Cost-effectiveness of tailoring anticoagulant therapy by a VTE recurrence prediction model in patients with venous thrombo-embolism as compared to care-as-usual: the VISTA study.* - The VISTA study
niversitair Medisch Centrum Utrecht0 个研究点目标入组 968 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 968
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •The study population consists of consecutive patients with an unprovoked (idiopathic) VTE of the lower extremities or lungs who are referred to the Thrombosis Services for treatment with vitamin K antagonists. All patients have to be 18 years of age or older when inclusion takes place.
排除标准
- •Patients with an initial indication for longer treatment with VKA (1 year or longer) * such as patients with recurrent VTE within 10 years, other indications like Atrial Fibrillation or Prosthetic heart valve. Ongoing malignancy (last treatment < 6months prior to VTE event). Only short term indication of VKA use (3 months) , conform current guidelines. This is surgery with general or spinal anaesthesia or lower limb fracture with casting within 3 months prior to diagnosis. VTE patients who are pregnant/ within first 6 weeks after labour. Physician states reason not to continue VKA therapy after 6 months of treatment (eg. bleeding risk). Participation in another trial.
- •Not willing or not able to give consent.
研究者
相似试验
尚未招募
不适用
Het VISTA onderzoek:Het VTE-predictiemodel als leidraad voor de duur van antistollingstherapie binnen de huidige richtlijnen voor patiënten met een veneuze-tromboembolie.(Recurrent) Venous thromboembolismDeep vein thrombosis(recidief) veneuze trombo-emboliediep veneuze tromboselongembolieVKA treatment durationrecurrent VTE prediction modelPulmonary EmbolismNL-OMON25558trecht University/ Utrecht University Medical Center1,500
已完成
不适用
The Warfarin/Aspirin Study in Heart failureHeart diseaseCirculatory SystemISRCTN76146656Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)279
已完成
不适用
Efficacy and safety of anticoagulant treatment using new alternative antithrombotic agents in acute cardioembolic stroke with nonvalvular atrial fibrillation.cerebral infarctionJPRN-UMIN000010477Department of Neurology, Kansai Medical University50
招募中
不适用
Efficacy and safety of anticoagulant treatment using New oral anticoagulant (edoxaban) in atrial fibrillation after cardiac surgery.arterial fibrillation after cardiac surgery (nonvalvular disease)JPRN-UMIN000021138ihon University school of medicine150
已完成
不适用
A Study of Safety and efficacy of anticoagulant therapy in the treatment of Atrial Fibrillation in KANAGAWAAtrial fibrillationJPRN-UMIN000011830ASSAF-K steering committee5,000